Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
ILG-R52H3 | Rhesus macaque | Rhesus macaque IL-2 R gamma / CD132 Protein, His Tag (MALS verified) |
|
||
ILA-M82E3 | Mouse | Biotinylated Mouse IL-2 R gamma Protein, His,Avitag™ (MALS verified) |
|
||
ILA-M52H3 | Mouse | Mouse IL-2 R gamma / CD132 Protein, His Tag (MALS verified) |
|
||
ILA-H52H5 | Human | Human IL-2 R gamma / CD132 Protein, His Tag (MALS verified) |
|
||
ILG-H85E8 | Human | Biotinylated Human IL-2 R gamma / CD132 Protein, His,Avitag™ |
|
||
ILG-H5256 | Human | Human IL-2 R gamma / CD132 Protein, Fc Tag |
|
The purity of Rhesus macaque IL-2 R gamma Protein, His Tag (Cat. No. ILG-R52H3) is more than 85% and the molecular weight of this protein is around 50-65 kDa verified by SEC-MALS.
The purity of Biotinylated Mouse IL-2 R gamma Protein, His,Avitag (Cat. No. ILA-M82E3) is more than 85% and the molecular weight of this protein is around 40-55 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Nanrilkefusp alfa | SO-C101; RLI-15; CYP-0150; SOT-101 | Phase 2 Clinical | Microsatellite instability-high cancer; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Thymus Neoplasms; Urinary Bladder Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Diseases; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Anus Neoplasms; Ovarian Neoplasms; Biliary Tract Neoplasms | Details | |
MB-107 | IND-14570; MB-107 | Phase 2 Clinical | St Jude Children's Research Hospital, National Institute Of Allergy And Infectious Diseases (Niaid), National Heart, Lung And Blood Institute, National Institute of Health, Islamabad | X-Linked Combined Immunodeficiency Diseases; Immunologic Deficiency Syndromes | Details |
GI-101 | SIM-323; SIM323; GI-101 | Phase 2 Clinical | GI Innovation Inc | Solid tumours; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Vaginal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Urinary Bladder Neoplasms; Sarcoma; Vulvar Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis | Details |
THOR-707 | THOR-707; SAR-444245 | Phase 2 Clinical | Synthorx Inc | Oropharyngeal Neoplasms; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Esophageal adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; Intestinal Neoplasms; Mesothelioma; Skin Neoplasms; Lymphoma, Large B-Cell, Diffuse; Hodgkin Disease; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Head and Neck Neoplasms | Details |
REGN-7257 | REGN-7257 | Phase 2 Clinical | Anemia, Aplastic | Details | |
IAP-0971 | IAP-0971 | Phase 2 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Solid tumours; Neoplasms; Urinary Bladder Neoplasms | Details |
TransCon IL-2 β/γ | Phase 2 Clinical | Ascendis Pharma A/S | Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms; Neoplasm Metastasis | Details | |
TYF-IL-2Rg gene-modified autologous stem cells (Shenzhen Geno-Immune Medical Institute) | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | X-Linked Combined Immunodeficiency Diseases | Details | |
Simlukafusp alfa | FAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FP | Phase 1 Clinical | F. Hoffmann-La Roche Ltd | Head and Neck Neoplasms; Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Breast Neoplasms; Uterine Cervical Neoplasms; Melanoma | Details |
BJ-001(Boji Biomedical Technology) | BJ-001 | Phase 1 Clinical | Boji Biomedical Technology (Hangzhou) Co Ltd | Solid tumours; Communicable Diseases; Neoplasm Metastasis | Details |
NL-201 (Neoleukin Therapeutics) | NL-201 | Phase 1 Clinical | Neoleukin Therapeutics Inc | Solid tumours | Details |
Recombinant human interleukin 15(Beijing Kawin) | Phase 1 Clinical | Beijing Kawin Technology Share-Holding Co Ltd | Solid tumours | Details | |
Nanrilkefusp alfa | SO-C101; RLI-15; CYP-0150; SOT-101 | Phase 2 Clinical | Microsatellite instability-high cancer; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Squamous Cell; Colorectal Neoplasms; Thymus Neoplasms; Urinary Bladder Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Thyroid Diseases; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Anus Neoplasms; Ovarian Neoplasms; Biliary Tract Neoplasms | Details | |
MB-107 | IND-14570; MB-107 | Phase 2 Clinical | St Jude Children's Research Hospital, National Institute Of Allergy And Infectious Diseases (Niaid), National Heart, Lung And Blood Institute, National Institute of Health, Islamabad | X-Linked Combined Immunodeficiency Diseases; Immunologic Deficiency Syndromes | Details |
GI-101 | SIM-323; SIM323; GI-101 | Phase 2 Clinical | GI Innovation Inc | Solid tumours; Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Vaginal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Urinary Bladder Neoplasms; Sarcoma; Vulvar Neoplasms; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Neoplasm Metastasis | Details |
THOR-707 | THOR-707; SAR-444245 | Phase 2 Clinical | Synthorx Inc | Oropharyngeal Neoplasms; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Esophageal adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Colorectal Neoplasms; Intestinal Neoplasms; Mesothelioma; Skin Neoplasms; Lymphoma, Large B-Cell, Diffuse; Hodgkin Disease; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Head and Neck Neoplasms | Details |
REGN-7257 | REGN-7257 | Phase 2 Clinical | Anemia, Aplastic | Details | |
IAP-0971 | IAP-0971 | Phase 2 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Solid tumours; Neoplasms; Urinary Bladder Neoplasms | Details |
TransCon IL-2 β/γ | Phase 2 Clinical | Ascendis Pharma A/S | Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms; Neoplasm Metastasis | Details | |
TYF-IL-2Rg gene-modified autologous stem cells (Shenzhen Geno-Immune Medical Institute) | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | X-Linked Combined Immunodeficiency Diseases | Details | |
Simlukafusp alfa | FAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FP | Phase 1 Clinical | F. Hoffmann-La Roche Ltd | Head and Neck Neoplasms; Solid tumours; Carcinoma, Renal Cell; Esophageal Neoplasms; Breast Neoplasms; Uterine Cervical Neoplasms; Melanoma | Details |
BJ-001(Boji Biomedical Technology) | BJ-001 | Phase 1 Clinical | Boji Biomedical Technology (Hangzhou) Co Ltd | Solid tumours; Communicable Diseases; Neoplasm Metastasis | Details |
NL-201 (Neoleukin Therapeutics) | NL-201 | Phase 1 Clinical | Neoleukin Therapeutics Inc | Solid tumours | Details |
Recombinant human interleukin 15(Beijing Kawin) | Phase 1 Clinical | Beijing Kawin Technology Share-Holding Co Ltd | Solid tumours | Details |
This web search service is supported by Google Inc.